INTEGRATED ORAL HEALTH CARE
Dr Ajesh George, Professor of Interprofessional Oral Health, School of Nursing and Midwifery, Western Sydney University (WSU) & Director and Co-Founder, Australian Centre for Integration of Oral Health
RESEARCHER PROFILE
Filmed in Sydney, Australia | August 2025
Dr Ajesh George is a Professor of Interprofessional Oral Health in the School of Nursing and Midwifery, Western Sydney University (WSU) and Honorary Professor in the School of Dentistry at The University of Sydney. He is a dentist with extensive experience in integrated oral health care and is a renowned expert globally in providing oral health training to non-dental professionals and translating oral health guidelines into their practice. Dr George is also the Director and Co-founder of the “Australian Centre for Integration of Oral Health” (ACIOH) which is a leading national research centre led by WSU in collaboration with various partners including universities, health services and professional organisations.
Over the last decade Dr George has been coordinating multidisciplinary teams in implementing effective and sustainable models of care across the lifespan and his work has been recognised by key bodies including the World Health Organisation. He has also been instrumental in training nurses and midwives to promote oral health by integrating oral health into undergraduate courses at Australian Universities as well as developing nationally recognised oral health professional development training programs.
Prof George has over $5.4M in funding including NHMRC grants, more than 150 publications (90% Q1/Q2 journals), 175 conference presentations (40 international), 19 research awards and a H-index of 34 with 4367 citations. He has 13 PhD and Masters completions and currently supervises 11 HDR students most of whom have received scholarships. In 2021 and 2024 Prof George was recognised as one of the top 2% scientists worldwide
Source: Supplied
You Might also like
-
Muscle Cell Communication and Repair
Dr. William Roman is a Group Leader at the Australian Regenerative Medicine Institute (ARMI) at Monash University. He obtained his PhD from Paris Descartes University and Freie University of Berlin, focusing on nuclear positioning during skeletal muscle development. Dr. Roman’s research journey has taken him across the globe, including postdoctoral work in Barcelona, tissue engineering in Lisbon, and a brief stint at Stanford University.
At ARMI, Dr. Roman leads innovative research on intercellular communication within muscle organs. His work involves growing human muscles on chips to understand how skeletal muscle cells interact with neurons and tendons. This research aims to develop better models for studying muscle diseases, drug screening, and even applications in cellular agriculture and biorobotics.
-
Interventions for improving outcomes of children who are deaf or hard of hearing
Professor Teresa Ching is a Conjoint Professor at NextSense Institute and Macquarie University, and an Honorary Professor at the University of Queensland in Australia. Her current research focuses on devising culturally sensitive practices in early detection and intervention to maximise children’s outcomes. Working with international colleagues, her current research is also directed towards developing global guidelines and recommendations for hearing screening beyond the newborn period, so that all children can benefit from early detection and intervention. The ultimate goal is to attain equity of care and outcomes for all children with hearing difficulties.
-
Role of metabolic dysfunction in advanced prostate cancer
Dr Gunter was drawn to the area of prostate cancer research and the intersection between chronic metabolic disorders and their emerging relationship to cancer. Her strengths include expertise in the metabolic syndrome, insulin signalling and metabolism, and she has a demonstrated record of successful and productive research projects in metabolic research where she now applies her efforts to understanding the role of metabolic dysfunction in advanced prostate cancer.